ACAMS’ 12th Annual AML & Anti-Financial Crime Conference – APAC Takes Cutting-Edge Look at the Perils and Promise of Compliance Efforts in the Asia Pacific Region
April 20, 2021 19:00 ET
|
Association of Certified Anti-Money Laundering Specialists
Hong Kong / Singapore, April 20, 2021 (GLOBE NEWSWIRE) -- As part of its ongoing effort to help compliance professionals meet evolving regulatory expectations in the Asia Pacific region, ACAMS will...
Mexico’s Leading Neobank albo Partners with Acuant to Tackle AML/KYC Compliance
March 23, 2021 07:00 ET
|
Acuant
LOS ANGELES, March 23, 2021 (GLOBE NEWSWIRE) -- Acuant, a leading global provider of identity verification solutions, today announced a partnership with albo, Mexico’s leading Neobank, which has...
Acuant and Scalable Solutions Partner to Streamline AML/KYC Compliance
March 09, 2021 07:00 ET
|
Acuant
LOS ANGELES, March 09, 2021 (GLOBE NEWSWIRE) -- Acuant, a leading global provider of identity verification solutions, and Scalable Solutions, a white label digital asset exchange provider, today...
Feedzai’s Financial Crime Report: Fraud Attacks Skyrocketed in 2020
March 04, 2021 04:00 ET
|
Feedzai Inc
650% increase in Account Take Over scams from Q4 2020 as compared to Q1 2020 250% increase in online banking fraud attacks178% fraud rate increase for digital media70% of all fraud is driven by card...
Precipio Signs HemeScreen™ Deals with Two Leading Oncology Groups
January 20, 2021 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has signed agreements with two of the largest oncology practices in the US,...
Global Data Consortium Partners with Boku to Bring Mobile Network Data to Compliant Customer Onboarding
January 14, 2021 12:00 ET
|
Boku Inc.
LONDON, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Boku Inc., (AIM: BOKU), the world's leading provider of mobile payment and identity solutions, and Global Data Consortium (GDC), the industry leader in...
Precipio Signs Sales & Marketing Agreement for HemeScreen™ with Major Oncology Distributor
December 10, 2020 10:15 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has entered into an agreement with a major US-based oncology distributor to...
Aprea Therapeutics Receives FDA Fast Track Designation for Eprenetapopt in the Treatment of TP53 Mutant Acute Myeloid Leukemia (AML)
November 30, 2020 08:00 ET
|
Aprea Therapeutics
BOSTON, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate the...
North America Anti-money Laundering (AML) Market 2020-2026 by Component, Deployment Type, Product, End-user
October 29, 2020 06:13 ET
|
Research and Markets
Dublin, Oct. 29, 2020 (GLOBE NEWSWIRE) -- The "North America Anti-money Laundering Market by Component, Deployment Type, Product, End-user and Country: Industry Analysis and Forecast 2020-2026"...
Rafael Pharmaceuticals Crosses Enrollment of 100th Patient in Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (Devimistat) for Relapsed or Refractory Acute Myeloid Leukemia (AML)
October 27, 2020 09:00 ET
|
Rafael Pharmaceuticals, Inc.
CRANBURY, N.J., Oct. 27, 2020 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, announced today that...